| 24小時(shí)熱門版塊排行榜 |
| 42 | 1/1 | 返回列表 |
| 查看: 1879 | 回復(fù): 41 | |||
| 【有獎(jiǎng)交流】積極回復(fù)本帖子,參與交流,就有機(jī)會(huì)分得作者 123n 的 24 個(gè)金幣 ,回帖就立即獲得 2 個(gè)金幣,每人有 1 次機(jī)會(huì) | |||
123n木蟲(chóng) (正式寫手)
|
[交流]
美國(guó)芝加哥大學(xué)Zhou Lab招聘化學(xué),化學(xué)生物學(xué),或者抗體/蛋白質(zhì)工程背景博后
|
||
|
Position Title: Postdoc in Chemical Biology and Protein/Antibody Engineering Division/Department: Biological Sciences Division; Department of Radiation and Cellular Oncology; Department of Chemistry Faculty Sponsor: Jie Zhou, Ph.D. Assistant Professor Lab introduction The Zhou Lab at the University of Chicago is seeking an enthusiastic and dedicated Postdoctoral Researcher with a strong interest in the development of targeted immunotherapies with chemical biology and protein/antibody engineering approaches. We work at the vibrant interface of chemistry and biology, with a specific focus on the complex dynamics of cell surfaces within the tumor microenvironment (TME). This interdisciplinary position presents an excellent opportunity for a Ph.D. graduate seeking to make significant contributions to the field of protein/antibody engineering & immunotherapy. This position offers an opportunity to work in a dynamic, collaborative environment within the Department of Radiation & Cellular Oncology and the Department of Chemistry at the University of Chicago. You'll work closely with Dr. Zhou, who has extensive experience and training in peptide chemistry, chemical biology, protein/antibody/cell engineering, and immunotherapy. The Zhou Lab is also part of the University of Chicago Comprehensive Cancer Center, offering additional opportunities for collaborative research and career development. For more information: https://voices.uchicago.edu/jzhoulab/research-2/ https://biologicalsciences.uchicago.edu/faculty/jie-zhou https://chemistry.uchicago.edu/faculty/jie-zhou Projects and technologies The successful candidate will be integral to our ongoing research projects, with a focus on: • Elucidating new chemical and biological phenomena or mechanisms on cell membranes contributing to pathological phenotypes. • Harnessing these insights to drive the development of next-generation immunotherapies. • Engineering small molecules and biologics to enhance our understanding of diseases and facilitate the creation of innovative therapeutics. The potential candidate will employ a diverse range of methodologies/technologies, including synthetic chemistry, proteomics, functional genomics, and protein/antibody/cell engineering. They will also leverage combinatorial selection technologies such as phage/yeast/cell/virus display, coupled with next-generation sequencing (NGS) and bioinformatics, to advance biological research. Qualification The selected individual is expected to proficiently manage multiple and competing projects and to maintain comprehensive and clear research notes. The successful candidate should be capable of presenting their research progress in internal group meetings and external scientific seminars to the broader scientific community within and outside the University of Chicago. We are seeking candidates who are highly independent, resourceful, and passionate about pioneering cancer immunotherapies. A Ph.D. or educational equivalent required Ph.D. in chemistry, chemical biology or biochemistry are preferred. Organic chemistry background OR experience of molecular biology experiments, such as cloning, protein expression and purification, is appreciated. Knowledge of basic immunological concepts is appreciated. Experience in combinatorial selection technologies, next-generation sequencing (NGS), and bioinformatics is highly desirable. Ability to write and verbalize clear and complete research findings in the English language. Demonstrated ability to work independently and as a team member. Benefit Compensation in the Biological Sciences Division follows the NIH NRSA Stipend scale. Additional information on benefits and being a postdoc in the University of Chicago Biological Sciences Division can be found at https://bsdpostdoc.uchicago.edu/. The University of Chicago is an Affirmative Action/Equal Opportunity/Disabled/Veterans Employer Contact Motivated candidates should submit a CV with names of 2-3 referees to Dr. Jie Zhou at jiezhou6@uchicago.edu. We look forward to your application and the potential to welcome you to our team. |
» 搶金幣啦!回帖就可以得到:
+1/180
+1/92
+1/86
+1/86
+1/84
+1/80
+1/32
+1/25
+1/17
+1/14
+1/11
+1/10
+1/8
+1/7
+1/6
+1/3
+1/3
+1/3
+1/2
+1/1
木蟲(chóng) (文壇精英)
禁蟲(chóng) (文學(xué)泰斗)
|
本帖內(nèi)容被屏蔽 |
木蟲(chóng) (正式寫手)
專家顧問(wèn) (文壇精英)
![]() |
專家經(jīng)驗(yàn): +584 |
木蟲(chóng) (文壇精英)













| 42 | 1/1 | 返回列表 |
| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|
|
[考研] 0856材料與化工求調(diào)劑! +5 | 化工考生111 2026-03-04 | 11/550 |
|
|---|---|---|---|---|
|
[考博] 26申博-目前4篇SCI一作 +4 | chen_2024 2026-03-02 | 4/200 |
|
|
[考研] 289求調(diào)劑 +3 | 馳光絕景 2026-03-04 | 3/150 |
|
|
[考研] 304求調(diào)劑 +4 | 曼殊2266 2026-03-05 | 4/200 |
|
|
[考研] 紡織、生物、化學(xué)、材料等專業(yè) +3 | Eember. 2026-03-05 | 7/350 |
|
|
[考研] 290求調(diào)劑 +5 | Bananaiy 2026-03-04 | 5/250 |
|
|
[考研] 一志愿天津大學(xué)085600 319分 材料與化工 金屬方向 求調(diào)劑 +6 | 青科11 2026-03-02 | 6/300 |
|
|
[考研] 281電子信息求調(diào)劑 +5 | jhtfeybgj 2026-03-02 | 9/450 |
|
|
[考研] 22408-273求調(diào)劑-擔(dān)任3個(gè)項(xiàng)目的負(fù)責(zé)人-1篇國(guó)際期刊論文(一作)1篇核心期刊論文在投。 +3 | 沒(méi)想好取什么名 2026-03-03 | 3/150 |
|
|
[考研] 一志愿鄭州大學(xué),學(xué)碩,物理化學(xué), 333求調(diào)劑 +5 | 李魔女斗篷 2026-03-04 | 5/250 |
|
|
[考研] 292求調(diào)劑 +9 | yhk_819 2026-02-28 | 9/450 |
|
|
[考研] 312求調(diào)劑 +8 | 醋精華了一下發(fā)?/a> 2026-03-03 | 10/500 |
|
|
[考博] 26申博 求博導(dǎo) +3 | 愛(ài)讀書的小帥 2026-02-28 | 5/250 |
|
|
[考研] 276求調(diào)劑 +8 | 路lyh123 2026-02-28 | 10/500 |
|
|
[考研] 求調(diào)劑 +4 | Guo_yuxuan 2026-03-02 | 5/250 |
|
|
[考研] 0856調(diào)劑 +10 | 劉夢(mèng)微 2026-02-28 | 10/500 |
|
|
[考研] 295求調(diào)劑。一志愿報(bào)考鄭州大學(xué)化學(xué)工藝學(xué)碩,總分295分 +8 | yl1 2026-03-02 | 9/450 |
|
|
[考研] 一志愿中石油(華東)本科齊魯工業(yè)大學(xué) +3 | 石能偉 2026-03-02 | 3/150 |
|
|
[考研] 303求調(diào)劑 +5 | 今夏不夏 2026-03-01 | 5/250 |
|
|
[論文投稿]
求助coordination chemistry reviews 的寫作模板
10+3
|
ljplijiapeng 2026-02-27 | 4/200 |
|